baber/WOPTO huggingface dataset:
Patent NZ-596046-A (NZ)
Title: Intraocular lens delivery system with a disposable plunger segment and method of use therefor
Inventor: MUCHHALA SUSHANT
IPC: A61F2/16
Filed: 2010-05-19
Abstract: A kit for an intraocular lens delivery system. The kit has a disposable plunger tip segment with an elongated body having a proximate end and a distal end. The kit has a fastening mechanism, which is a projection, a cavity or both, at the proximate end of the elongated body. The kit has a pushing surface at the distal end of the elongated body. The elongated body and fastening projection or cavity are integrally moulded of polymeric material. The fastening mechanism releasably attaches the disposable segment to a reusable plunger segment of the intraocular lens delivery system. The polymeric material has a flexural modulus of at least 3500 MPa. The kit has a disposable tool with a shaped cavity corresponding to a shaped portion of the disposable segment and is used to attach or detach the disposable segment to the reusable segment. The kit also has a disposable cartridge that is attachable or detachable from a housing.
Patent NZ-598749-A (NZ)
Title: Fused heterocyclic ring derivative and use thereof
Inventor: SASAKI SATOSHI
IPC: A61K31/5377
Filed: 2010-08-25
Abstract: Disclosed herein are fused pyrrolo[3,2-c]pyridine compounds of formula (CI) wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful for their stong Smo inhibitory activity and as such is useful in the treatment of cancer.
Patent NZ-601493-A (NZ)
Title: Reticulated stereo module for the construction of buildings, and construction method
Inventor: RODRIGUEZ OSVALDO NESTOR
IPC: E04B1/19
Filed: 2011-01-19
Abstract: A modular building block for constructing a building. The block has a tetrahedral element that includes six bars fixed to each other at four vertexes. Two of the vertexes are lower vertexes and two of the vertexes are upper vertexes disposed at a vertical location above the two lower vertexes. The block has first and second tension members. The first tension member includes a first end that is fixed to a first one of the upper vertexes and a second end. The second tension member includes a first end that is fixed to a second one of the upper vertexes and a second end. The first and second tension members are parallel to each other and are oriented in a vertical direction. A floor panel at a base of the modular building block that is oriented horizontally. The floor panel is fixed to the second ends of the first and second tension members and is fixed to the two lower vertexes.
Patent NZ-601607-A (NZ)
Title: Piperazines as antimalarial agents
Inventor: AISSAOUI HAMED
IPC: A61K31/495
Filed: 2011-01-04
Abstract: The disclosure relates to piperazine derivatives of Formula I and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing one or more of those compounds and their use as medicaments for the treatment or prevention of protozoal infections, such as especially malaria. Compounds of the invention include: (S)-N-[4-(4-Acetyl-piperazin-1-yl)-benzyl]-N-{ 1-benzyl-2-[4-(4-cyano-benzyl)-piperazin-1-yl]-2-oxo-ethyl} -3-(4-isopropyl-phenyl)-acrylamide, (S)-N-[4-(4-Acetyl-piperazin-1-yl)-benzyl]-N-{ 1-benzyl-2-[4-(4-cyano-benzyl)-piperazin-1-yl]-2-oxo-ethyl} -3-(4-trifluoromethoxy-phenyl)-acrylamide, (S)-N-[4-(4-Acetyl-piperazin-1-yl)-benzyl]-N-[1-benzyl-2-(4-benzyl-piperazin-1-yl)-2-oxoethyl]-3-(4-ethyl-phenyl)-acrylamide, (S)-N-[4-(4-Acetyl-piperazin-1-yl)benzyl]-N-{ 1-[4-(4-(dimethylamino )benzyl)piperazin-1-yl]-1-oxo-3-phenylpropan-2-yl} -3-(p-tolyl)acrylamide and (S)-N-[4-(4-Acetyl-piperazin-1-yl)-benzyl]-N-{ 1-benzyl-2-[4-(4-dimethylaminobenzyl)piperazin-1-yl]-2-oxo-ethyl} -3-(4-ethoxy-phenyl)-acrylamide,
Patent NZ-603155-A (NZ)
Title: Phospholipid drug analogs
Inventor: MAJ ROBERTO
IPC: A61K47/48
Filed: 2011-04-29
Abstract: ABSTRACT - 603155 The disclosure relates to compositions comprising a compound having a structure according to Formula A or Formula B: or a pharmaceutically acceptable salt, tautomer or hydrate thereof, where X2 is a bond or linker, X3 is bond or -PO4-, and X1, R1, R2, R3, and n are as described in the specification. These compounds are suitable for treating cancer conditions selected from a bladder cancer condition, skin precancerous or cancerous condition. Also disclosed are methods for making and using such compounds and compositions.
Patent NZ-603545-A (NZ)
Title: Ciprofloxacin dry syrup composition
Inventor: JAVERI UMA RAJAN
IPC: A61K9/00
Filed: 2010-06-03
Abstract: ABSTRACT - 603545 Disclosed herein is a microencapsulation process for preparation of taste masked dry syrup composition of ciprofloxacin comprising ciprofloxacin taste masked granules along with at least one pharmaceutically acceptable excipient, wherein the process comprises the steps of: (a) granulating the ciprofloxacin base micro-particles with granulating agents selected from Eudragit EPO (methacrylate co-polymer), HPMC, HPC and combinations thereof; (b) coating the granules of step (a) with the coating solution of methacrylate co-polymer in solvent selected from isopropyl alcohol, ethanol, methylene chloride, water and combinations thereof to obtain taste masked ciprofloxacin granules; (c) mixing taste masked ciprofloxacin granules of step (b) with suspending agent, sweeteners, flavour, glidant, lubricant and buffering agent to obtain dry syrup and (d) packing the dry syrup of step (c) into single dose sachet or multiple dose container, wherein preferably ciprofloxacin base is incorporated in an amount of 250 mg.
Patent NZ-610689-A (NZ)
Title: Substituted 6-amino-nicotinamides as kcnq2/3 modulators
Inventor: KÜHNERT SVEN
IPC: A61K31/44
Filed: 2011-10-19
Abstract: Provided are substituted 6-amino-nicotinamide compounds of the general formula (I) where the variables are defined in the specification. Examples of the compounds include N-[(3,5-Difluoro-phenyl)-methyl]-2-ethylsulfanyl-4-methyl-6-morpholin-4-ylpyridine-3-carboxylic acid amide and N-(4,4-Dimethyl-pentyl)-4-methyl-6-morpholin-4-yl-2-tetrahydro-pyran-4-ylpyridine-3-carboxylic acid amide. The compounds are modulators of voltage gated potassium (K+) channels KCNQ2/3 (Kv7.2/7.3). Further provided are pharmaceutical compositions comprising the compounds and methods of treating pain and neurological disorders.
Patent NZ-617347-A (NZ)
Title: Pentylenetetrazole derivatives
Inventor: LIEN LYNDON
IPC: C07D487/04
Filed: 2012-05-03
Abstract: The disclosure relates to pentylenetetrazole (PTZ) derivates having formula (l) wherein R1 – R10 are independently selected from hydrogen and deuterium, wherein at least one is not hydrogen, or a pharmaceutically salt thereof. The disclosure also relates to pharmaceutical compositions comprising these compounds and their use in the increasing blood flow, heart rate or breathing rate in an individual The disclosure also relates to their use for treating senility, senile confusion, psychoses, psychoneuroses when anxiety and nervous tension were present, cerebral arteriosclerosis, nausea, depression, fatigue, debilitation, mild behavioral disorders, irritability, emotional instability, antisocial attitudes, anxiety, vertigo or incontinence, or symptom thereof, or in improving cognitive function in individuals, for instance, in individuals with Down syndrome and other conditions. Example compounds include: 6,6,8,8,10,10-d6-6,7,8,9-tetrahydro-5Htetrazolo[1,5-a]-azepine
Patent NZ-617535-A (NZ)
Title: Methods and apparel for attenuating electromagnetic fields emanating from a person
Inventor: SLINKARD MICHAEL D
IPC: G21F3/02
Filed: 2010-04-22
Abstract: 617535 Disclosed is an article of apparel when used for attenuating or blocking electromagnetic fields and scent or odour emanating from a human body, to avoid detection from an animal. The article of apparel has an electromagnetically shielding fabric (40) that includes a substantially continuous system of conductive fibres (44) combined with a non-conductive fabric (42). The conductive fibres (44) are also configured to attenuate an emanating scent or odour from the human body. The shielding fabric (40) attenuates the emanated electromagnetic field at frequencies less than about 1 gigahertz.
Patent NZ-704995-A (NZ)
Title: Control gates and valves
Inventor: AUGHTON DAVID JOHN
IPC: G01F1/00
Filed: 2013-07-12
Abstract: A conventional Padman Stop has flexible material at either side of its rectangular panel, which material can be unstable during gate operation. The invention provides an overshot control gate (26) for use with trapezoidal irrigation channels (10). Gate (26) has a rigid rectangular section (38) adapted to, in use, be pivotally mounted to the base (12) of trapezoidal irrigation channel (10). A pair of triangular sections are pivotally mounted on opposite sides (60, 62) of the rigid rectangular section (38). Each of the triangular sections being divided into first and second triangular sections (44, 46, 52, 54) with a common apex (70, 72) at the base (12) of the trapezoidal irrigation channel (10). Each of the first triangular sections (44, 46) being rigid and adapted to, in use, be pivotally mounted (48, 50) to opposite side walls (14, 16) of trapezoidal irrigation channel (10). Each of the second triangular sections 52, 54) including the pivotal mounting on opposite sides (60, 62) of rectangular section (38) and being formed of a flexible material.
Patent NZ-708349-A (NZ)
Title: Egfr and c-met fibronectin type iii domain binding molecules
Inventor: ANDERSON MARK
IPC: C07K14/00
Filed: 2013-11-21
Abstract: Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are disclosed. These Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules are useful in the generation of therapeutic compositions for treating and diagnosing diseases and disorders including cancer.
Patent NZ-709269-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: A23K10/32
Filed: 2007-10-26
Abstract: Disclosed is a method of making a combustible fuel which is a hydrocarbon, the method comprising converting a pretreated biomass feedstock which comprises contacting the feedstock with one or more cellulolytic enzymes and utilizing a microorganism which is a fungus or bacterium or yeast to produce the combustible fuel, wherein the converting comprises fermentation with the fungus or bacterium or yeast, wherein the feedstock has been pretreated by irradiating with electron beam radiation at a dose of between 10 Mrad and 150 Mrad; and wherein the biomass feedstock comprises a cellulosic and/or lignocellulosic material.
Patent NZ-729521-A (NZ)
Title: Flexible packaging container
Inventor: ZUM-DOHME ROLF
IPC: B65D39/14
Filed: 2015-09-14
Abstract: A flexible packaging container, comprising a front wall (2) and a rear wall (3) as well as a holding space (15) between the walls (2, 3) for goods to be stored. The walls (2, 3) are made at least in part of a film. On the front inside wall there is an intermediate space (14) which is formed by an inner ply (4) and is separated from the holding space (15) by the inner ply (4), the holding space (15) can be evacuated into the intermediate space (14) via at least one holding space evacuation hole (7) in the inner ply (4), and the intermediate space (14) can be evacuated out of the packaging container (1) via at least one additional evacuation hole (11) that interrupts a transverse seam, thus forming a vent arrangement. The inner ply (4) is formed by a strip (4) fastened to the front wall (2) using two longitudinal seams extending between top and bottom transverse seams (5.1, 5.2). The container is closed by a longitudinal seam (12) that seals the packaging container. The longitudinal seam does not extend to the front wall. Since the vent is on the opposite side from the longitudinal seam, venting of the container is much easier. The front wall is provided with printing for identification/ advertising purposes.
Patent NZ-739082-A (NZ)
Title: Monitoring state of produce within transport containers
Inventor: JONES LEE
IPC: A23B7/148
Filed: 2016-07-26
Abstract: The invention relates to the monitoring of the state of produce within transport containers, with particular application to dynamic monitoring of the respiration rate of produce in controlled atmosphere container systems used in cargo container transportation. A method is provided for tracking, over an extended period, the respiration rate of produce contained in a leaky transport container, including the steps of, at intervals during said extended period, for a prescribed period, being a respiration rate data block (RRDB) cycle, ensuring that there is substantially no air passage between the interior and the exterior of the transport container other than leakage, identifying the leakage rate of the transport container, measuring, at intervals over said RRDB cycle, the concentration of one or more constituent gases in the transport container as the produce respires; and calculating, at a logic unit, from said measurements of concentrations of said one or more constituent gases and said leakage rate, a respiration rate of the produce for each RRDB cycle. In a controlled atmosphere container system, the method involves, under control of a controller, at intervals during said extended period, suspending controlled atmosphere (CA) operation and initiating a respiration rate monitoring (RRM) mode, in order to measure the concentration of the one or more constituent gases in the transport container as the produce respires, from which the respiration rate can be calculated.
Patent NZ-751056-A (NZ)
Title: Production of pulse protein product
Inventor: GREEN BRENT E
IPC: A23J3/28
Filed: 2014-03-10
Abstract: A pulse protein product having a protein content of at least about 50 wt% (N x 6.25) d.b. is recovered in the processing of pulse protein source material to form pulse protein products wherein the pulse protein source is extracted in one embodiment with calcium salt solution. The resulting pulse protein solution is separated from the bulk of the residual pulse protein source and then the pulse protein solution is processed to remove finer residual solids, which are optionally washed and then dried to provide the pulse protein product. In another embodiment, the pulse protein source is extracted with water, the bulk of the residual protein source removed and the resulting pulse protein solution treated with calcium salt to precipitate phytic acid. The precipitated phytic acid and any finer residual solids remaining in solution after the initial separation step are removed from the pulse protein solution then optionally washed and dried to provide the pulse protein product.
Patent NZ-766453-A (NZ)
Title: Method of producing natural killer cells and composition for treating cancer
Inventor: PARK SANG WOO
IPC: A61P31/12
Filed: 2019-01-31
Abstract: A method for producing natural killer cells is disclosed. The method comprises isolating peripheral blood mononuclear cells (PBMCs) from a blood sample; isolating at least one of CD56+ cells and/or CD3-/CD56+ cells from the PBMCs; and co-culturing the at least one of CD56+ cells and/or CD3-/CD56+ cells with a combination of feeder cells in the presence of a cytokine. A composition for treating cancer is also disclosed. The composition comprises the CD56+ natural killer cells produced by the disclosed method and a cytokine.
Patent NZ-768700-A (NZ)
Title: Systems and methods for forming and maintaining a high performance frc
Inventor: BINDERBAUER MICHL
IPC: H05H3/00
Filed: 2015-10-30
Abstract: A high performance field reversed configuration (FRC) system includes a central confinement vessel, two diametrically opposed reversed-field-theta-pinch formation sections coupled to the vessel, and two divertor chambers coupled to the formation sections. A magnetic system includes quasi-dc coils axially positioned along the FRC system components, quasi-dc mirror coils between the confinement chamber and the formation sections, and mirror plugs between the formation sections and the divertors. The formation sections include modular pulsed power formation systems enabling static and dynamic formation and acceleration of the FRCs. The FRC system further includes neutral atom beam injectors, pellet or CT injectors, gettering systems, axial plasma guns and flux surface biasing electrodes. The beam injectors are preferably angled toward the midplane of the chamber. In operation, FRC plasma parameters including plasma thermal energy, total particle numbers, radius and trapped magnetic flux, are sustainable at or about a constant value without decay during neutral beam injection.
Patent NZ-775595-A (NZ)
Title: Balancing valve
Inventor: REY CHARLOTTE
IPC: F24D19/10
Filed: 2019-11-12
Abstract: The present invention proposes a balancing valve, a fluid network with such a balancing valve, and a method of maintaining such a balancing valve. The balancing valve comprises a housing having a main fluid passage extending along a main flow axis, a valve body disposed within the housing in the fluid passage, wherein the valve body has a first through hole forming a first fluid passage with a variable first fluid passage cross section. The valve body has a second through hole distinct from the first through hole and forming a second fluid passage in the valve body. The first fluid passage is a main fluid passage and the second fluid passage is a by-pass passage. The valve body is rotated using a by-pass knob with an asymmetrical orientation control element that cooperates with a removable by-pass stop device having an orientation pin to block the control element in a chosen orientation of the flow, and a stop pin to stop the by-pass knob in the by-pass position. The disclosed balancing valve is simpler to manufacture and maintain, can manage the flow rate of a fluid locally and doesn’t complicate the existing fluid network.
Patent PT-100913-A (PT)
Title: Prepn. of erythromycin 9-(O-((2-methoxy ethoxy)methyl)oxime - used as antibiotic active against Gram positive bacteria
Inventor: CRUZ ALBA AGUSTI
IPC: C07H17/08
Filed: 1992-09-29
Abstract: Prepn. of erythromycin 9-(O-((2-methoxy ethoxy)methyl)oxime) (roxitromicin) (I) comprises treating a 2-methoxy-ethoxymethyl ammonium salt of erythromycin-9-oxime of formula (V) (where X is an anion derived from an acid). Reaction is in a non alcoholic polar solvent.
Patent PT-106061-A (PT)
Title: Sistema e processo de fixação rápida de módulos de bagageira em veículos de transporte de passageiros e módulo de bagageira compreendendo o sistema de fixação rápida
Inventor: JESUS LEONEL DE
IPC: B60R5/00
Filed: 2011-12-19
Abstract: A PRESENTE INVENÇÃO DIVULGA UM SISTEMA DE ENCAIXE E FIXAÇÃO RÁPIDA DE MÓDULOS DE BAGAGEIRA PARA VEÍCULOS DE TRANSPORTE DE PASSAGEIROS, QUE PERMITE A MONTAGEM POR UM ÚNICO OPERADOR E A DESMONTAGEM SELETIVA DE QUALQUER DOS MÓDULOS PARA MANUTENÇÃO. O SISTEMA DE FIXAÇÃO COMPREENDE UMA ESTRUTURA (1) DE SUPORTE ALONGADA QUE POSSUI UM ELEMENTO (2) FÊMEA DISPOSTO AO LONGO DO SEU COMPRIMENTO; UM ELEMENTO (4) MACHO FLEXÍVEL, COM MEMÓRIA DE FORMA, DISPOSTO NUMA TAMPA (10) DO MÓDULO DE BAGAGEIRA A INSTALAR; UM ELEMENTO (6) DE FIXAÇÃO PRÉ-INSTALADO NA TAMPA (10) DO MÓDULO; E UM ELEMENTO (7) DE APERTO PREPARADO PARA COOPERAR COM O ELEMENTO (6) DE FIXAÇÃO, DE MODO A PRENDER E FIXAR FIRMEMENTE O ÚLTIMO, FIXANDO, ASSIM, O REFERIDO MÓDULO AO TETO DO VEÍCULO. A INVENÇÃO DIVULGA AINDA UM MÓDULO DE BAGAGEIRA UTILIZANDO O SISTEMA DE FIXAÇÃO ANTERIOR E UM PROCESSO DE ENCAIXE E FIXAÇÃO DO MÓDULO NO VEÍCULO.
Patent PT-108368-A (PT)
Title: Produção contínua de partículas
Inventor: MARCIO TEMTEM
IPC: A61K9/14
Filed: 2015-03-31
Abstract: A PRESENTE INVENÇÃO DIVULGA UM MÉTODO PARA PRODUZIR, EM MODO CONTÍNUO, MICRO E/OU NANOPARTÍCULAS DE COMPONENTE ÚNICO OU MULTI-COMPONENTE, TAIS COMO PARTÍCULAS DE DISPERSÕES SÓLIDAS AMORFAS OU CO-CRISTAIS. O MÉTODO CONTÍNUO COMPREENDE OS PASSOS DE 1. PREPARAR UMA PRIMEIRA SOLUÇÃO QUE COMPREENDE PELO MENOS UM COMPONENTE E PELO MENOS UM SOLVENTE E UMA SEGUNDA SOLUÇÃO QUE COMPREENDE PELO MENOS UM ANTI-SOLVENTE DE PELO MENOS UM COMPONENTE COMPREENDIDO NA PRIMEIRA SOLUÇÃO, 2. MISTURAR A REFERIDA PRIMEIRA SOLUÇÃO E A REFERIDA SEGUNDA SOLUÇÃO, POR MEIO DE I5 MICROFLUIDIZAÇÃO PARA PRODUZIR UMA SUSPENSÃO POR PRECIPITAÇÃO OU CO-PRECIPITAÇÃO, 3. ALIMENTAR A REFERIDA SUSPENSÃO A UM SISTEMA DE FILTRAÇÃO PARA SE OBTER UMA CORRENTE DE CONCENTRADO, 4. ALIMENTAR A REFERIDA CORRENTE DE CONCENTRADO A UM SECADOR POR ATOMIZAÇÃO; 5. ATOMIZAR A REFERIDA CORRENTE DE CONCENTRADO UTILIZANDO PELO MENOS UM ATOMIZADOR; 6. SECAGEM DA REFERIDA CORRENTE DE CONCENTRADO ATOMIZADA PARA SE OBTEREM PARTÍCULAS, 7. RECOLHER AS REFERIDAS PARTÍCULAS. PARTÍCULAS DE COMPONENTE ÚNICO OU PARTÍCULAS DE MULTI-COMPONENTE, PARTÍCULAS DE DISPERSÕES SÓLIDAS AMORFAS, PARTÍCULAS DE CO-CRISTAIS E AS COMPOSIÇÕES FARMACÊUTICAS SÃO TAMBÉM DIVULGADAS.
Patent PT-117780-A (PT)
Title: Implantes com estímulos elétricos customizados e seu método de obtenção
Inventor: FILIPE SAMUEL CORREIA PEREIRA DA SILVA
IPC: A61F2/28
Filed: 2022-02-08
Abstract: A PRESENTE DESCRIÇÃO DIZ RESPEITO A IMPLANTES ÓSSEOS COM CAPACIDADE DE ESTIMULAÇÃO ELÉTRICA CUSTOMIZADA PARA UTILIZAÇÃO PREFERENCIAL COMO IMPLANTES DE ANCA E JOELHO EM HUMANOS E OUTROS ANIMAIS E O RESPETIVO MÉTODO DE OBTENÇÃO. ESTE DISPOSITIVO PERMITE CRIAR MÚLTIPLOS CAMPOS ELÉTRICOS (6), ALOCADOS EM MÚLTIPLOS PONTOS DA SUPERFÍCIE DO IMPLANTE, ESTRATEGICAMENTE DEFINIDOS E CUSTOMIZADOS ÀS NECESSIDADES DO UTILIZADOR, QUANDO ATUADOS POR UMA FORÇA EXTERIOR (5). O SISTEMA ELÉTRICO NA ORIGEM DOS CAMPOS ELÉTRICOS CONSISTE EM REGIÕES DE MATERIAL PIEZOELÉTRICO, INTERNA OU NA SUPERFÍCIE (7), E, SE APLICÁVEL, NUM CIRCUITO ELÉTRICO COM POLO POSITIVO E NEGATIVO. COMO RESULTADO, PERMITEM EVITAR A PERDA ÓSSEA E ESTIMULAM A REGENERAÇÃO ÓSSEA E A ELIMINAÇÃO DE BACTÉRIAS NAS ZONAS CIRCUNDANTES AO IMPLANTE.
Patent RU-94001170-A (RU)
Inventor: BELJAEV E JU
IPC: A61K31/06
Filed: 1994-01-10
Abstract: FIELD: pharmaceutical industry. SUBSTANCE: polyethylene glycol-400 is added to the preparation composition that decreases the resorption degree. EFFECT: enhanced effectiveness of antifungal preparation.
Patent RU-94020471-A (RU)
Inventor: UMANETS V I
IPC: B22D11/10
Filed: 1994-06-01
Abstract: FIELD: metallurgy; continuous casting of metals. SUBSTANCE: liquid metal from ladle is delivered into vacuum chamber where residual pressure is built, then metal is delivered into pony ladle through branch pipe and further on into moulds out of which ingots are taken. Depth of branch pipe dipping in metal in pony ladle is changed by changing level of metal in ladle. In process of continuous casting metal in pony ladle is heated by plasma arc between metal level which serves as anode and graphite rod which serves as cathode. When depth of branch pipe dipping is changed, graphite rod is displaced accordingly to provide constant distance between and face of graphite rod and metal level. DC voltage supplied to rod is maintained constant. Position of metal level in pony ladle is judged by valve of travel of graphite rod. Device id intended for use in continuous casting installations. Essential illustration is provided. EFFECT: enhanced quality of continuously cast ingots, improved degassing of metal at continuous casting.
Patent RU-94025698-A (RU)
Inventor: APUKHTIN A F
IPC: A61B5/02
Filed: 1994-07-08
Abstract: FIELD: medicine; therapy. SUBSTANCE: method recommends to proceed to three-fold registration of tetrapolar rheovasogram before administration of preparation and upon expiration of 60 and 120 min. after its administration. Next therapeutist must assess orientation and extent of peripheral hemodynamic reaction. Variations of latter make it possible to calculate treatment efficiency prognosis factor, and if its value ranges from 7 to 15%, inference may be drawn on correct choice of treatment procedure and efficiency of treatment under way may be prognosticated. EFFECT: enhanced accuracy.